Literature DB >> 26079760

Lasso peptides: an intriguing class of bacterial natural products.

Julian D Hegemann1, Marcel Zimmermann1, Xiulan Xie1, Mohamed A Marahiel1.   

Abstract

Natural products of peptidic origin often represent a rich source of medically relevant compounds. The synthesis of such polypeptides in nature is either initiated by deciphering the genetic code on the ribosome during the translation process or driven by ribosome-independent processes. In the latter case, highly modified bioactive peptides are assembled by multimodular enzymes designated as nonribosomal peptide synthetases (NRPS) that act as a protein-template to generate chemically diverse peptides. On the other hand, the ribosome-dependent strategy, although relying strictly on the 20-22 proteinogenic amino acids, generates structural diversity by extensive post-translational-modification. This strategy seems to be highly distributed in all kingdoms of life. One example for this is the lasso peptides, which are an emerging class of ribosomally assembled and post-translationally modified peptides (RiPPs) from bacteria that were first described in 1991. A wide range of interesting biological activities are known for these compounds, including antimicrobial, enzyme inhibitory, and receptor antagonistic activities. Since 2008, genome mining approaches allowed the targeted isolation and characterization of such molecules and helped to better understand this compound class and their biosynthesis. Their defining structural feature is a macrolactam ring that is threaded by the C-terminal tail and held in position by sterically demanding residues above and below the ring, resulting in a unique topology that is reminiscent of a lariat knot. The ring closure is achieved by an isopeptide bond formed between the N-terminal α-amino group of a glycine, alanine, serine, or cysteine and the carboxylic acid side chain of an aspartate or glutamate, which can be located at positions 7, 8, or 9 of the amino acid sequence. In this Account, we discuss the newest findings about these compounds, their biosynthesis, and their physicochemical properties. This includes the suggested mechanism through which the precursor peptide is enzymatically processed into a mature lasso peptide and crucial residues for enzymatic recognition. Furthermore, we highlight new insights considering the protease and thermal stability of lasso peptides and discuss why seven amino acid residue rings are likely to be the lower limit feasible for this compound class. To elucidate their fascinating three-dimensional structures, NMR spectroscopy is commonly employed. Therefore, the general methodology to elucidate these structures by NMR will be discussed and pitfalls for these approaches are highlighted. In addition, new tools provided by recent investigations to assess and prove the lasso topology without a complete structure elucidation will be summarized. These include techniques like ion mobility-mass spectrometry and a combined approach of thermal and carboxypeptidase treatment with subsequent LC-MS analysis. Nevertheless, even though much was learned about these compounds in recent years, their true native function and the exact enzymatic mechanism of their maturation remain elusive.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26079760     DOI: 10.1021/acs.accounts.5b00156

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  91 in total

Review 1.  Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era.

Authors:  Kenton J Hetrick; Wilfred A van der Donk
Journal:  Curr Opin Chem Biol       Date:  2017-03-02       Impact factor: 8.822

2.  Elucidating the Specificity Determinants of the AtxE2 Lasso Peptide Isopeptidase.

Authors:  Mikhail O Maksimov; Joseph D Koos; Chuhan Zong; Bozhena Lisko; A James Link
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

3.  Discovery of Ubonodin, an Antimicrobial Lasso Peptide Active against Members of the Burkholderia cepacia Complex.

Authors:  Wai Ling Cheung-Lee; Madison E Parry; Chuhan Zong; Alexis Jaramillo Cartagena; Seth A Darst; Nancy D Connell; Riccardo Russo; A James Link
Journal:  Chembiochem       Date:  2020-01-03       Impact factor: 3.164

4.  Heterologous and in Vitro Reconstitution of Fuscanodin, a Lasso Peptide from Thermobifida fusca.

Authors:  Joseph D Koos; A James Link
Journal:  J Am Chem Soc       Date:  2018-12-27       Impact factor: 15.419

Review 5.  Advances in microbial culturing conditions to activate silent biosynthetic gene clusters for novel metabolite production.

Authors:  Hailey A Tomm; Lorena Ucciferri; Avena C Ross
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-08       Impact factor: 3.346

Review 6.  Occurrence, function, and biosynthesis of mycofactocin.

Authors:  Richard Ayikpoe; Vishnu Govindarajan; John A Latham
Journal:  Appl Microbiol Biotechnol       Date:  2019-02-18       Impact factor: 4.813

7.  The antimicrobial peptide database provides a platform for decoding the design principles of naturally occurring antimicrobial peptides.

Authors:  Guangshun Wang
Journal:  Protein Sci       Date:  2019-08-10       Impact factor: 6.725

8.  Evidence of Cis/Trans-Isomerization at Pro7/Pro16 in the Lasso Peptide Microcin J25.

Authors:  Kevin Jeanne Dit Fouque; Julian D Hegemann; Séverine Zirah; Sylvie Rebuffat; Ewen Lescop; Francisco Fernandez-Lima
Journal:  J Am Soc Mass Spectrom       Date:  2019-03-04       Impact factor: 3.109

9.  Characterization of the macrocyclase involved in the biosynthesis of RiPP cyclic peptides in plants.

Authors:  Jonathan R Chekan; Paola Estrada; Patrick S Covello; Satish K Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

10.  Isolation and structure determination of new linear azole-containing peptides spongiicolazolicins A and B from Streptomyces sp. CWH03.

Authors:  Mana Suzuki; Hisayuki Komaki; Issara Kaweewan; Hideo Dohra; Hikaru Hemmi; Hiroyuki Nakagawa; Hideki Yamamura; Masayuki Hayakawa; Shinya Kodani
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-20       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.